Concepedia

Belaydi Othmane

BO

Statistics

Publications

12

Citations

993

H-Index

12

Active since

2021

Affiliations

Xiangya Hospital Central South University(Current)

Central South University

Texas Medical Center

Houston Methodist

University of Rochester Medical Center

Belaydi Othmane is an author at Xiangya Hospital Central South University specializing in medicine, oncology, and molecular oncology.

Publications per year

2021–2023

12

Publications

12

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

Jiao Hu, Anze Yu, Belaydi Othmane et al. · Theranostics · 2021 · 454 citations · Full text

, , +17

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study

Jiao Hu, Jinbo Chen, Zhenyu Ou et al. · Cell Reports Medicine · 2022 · 141 citations · Full text

, , +17

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer

Jiao Hu, Belaydi Othmane, Anze Yu et al. · BMC Medicine · 2021 · 138 citations · Full text

, , +15

m<sup>6</sup>A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism

Peihua Liu, Benyi Fan, Belaydi Othmane et al. · Theranostics · 2022 · 62 citations · Full text

, , +17

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer

Zhi Liu, Tiezheng Qi, Xiaowen Li et al. · Frontiers in Immunology · 2021 · 37 citations · Full text

, , +17

1–5 of 12